Signet Ring Cell Carcinoma

Also known as: Signet-ring cell carcinoma / Signet ring cell carcinoma (morphologic abnormality) / Carcinoma, Signet Ring Cell

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB09035	Nivolumab	2	Active Not Recruiting	1
DB13896	Talimogene laherparepvec	2	Active Not Recruiting	1